Global Medical REIT Inc. (GMRE)
NYSE: GMRE · Real-Time Price · USD
7.66
+0.02 (0.26%)
Sep 12, 2025, 4:00 PM EDT - Market closed
Global Medical REIT Stock Forecast
Stock Price Forecast
The 2 analysts that cover Global Medical REIT stock have a consensus rating of "Buy" and an average price target of $10.38, which forecasts a 35.51% increase in the stock price over the next year. The lowest target is $9.00 and the highest is $11.75.
Price Target: $10.38 (+35.51%)
Analyst Consensus: Buy
* Price targets were last updated on May 8, 2025.
Analyst Ratings
The average analyst rating for Global Medical REIT stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 4 | 4 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Hold Maintains $10 → $9 | Hold | Maintains | $10 → $9 | +17.49% | May 8, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 12, 2025 |
| Berenberg | Berenberg | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +53.39% | Oct 18, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $11 → $10 | Strong Buy | Maintains | $11 → $10 | +30.55% | May 13, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $12 → $11 | Strong Buy | Maintains | $12 → $11 | +43.60% | May 8, 2023 |
Financial Forecast
Revenue This Year
149.43M
from 138.76M
Increased by 7.69%
Revenue Next Year
155.47M
from 149.43M
Increased by 4.04%
EPS This Year
0.07
from 0.01
Increased by 452.92%
EPS Next Year
0.07
from 0.07
Increased by 4.99%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 157.9M | 172.9M | ||
| Avg | 149.4M | 155.5M | ||
| Low | 138.4M | 141.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 13.8% | 15.7% | ||
| Avg | 7.7% | 4.0% | ||
| Low | -0.3% | -5.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.09 | 0.08 | |
| Avg | 0.07 | 0.07 | |
| Low | 0.04 | 0.06 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 668.4% | 23.5% | |
| Avg | 452.9% | 5.0% | |
| Low | 218.7% | -13.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.